Calidi Biotherapeutics raises $4.6M via warrant exercise at $0.70/share

Calidi Biotherapeutics, Inc.

Gross proceeds ~$4.6M from immediate exercise of 6,595,000 warrants at $0.70/share.
New Series H warrants issued for up to 6,595,000 shares at $0.70, exercisable after 6 months.
7 warrant holders participated; closing expected July 10, 2025.
Net proceeds for clinical programs and working capital.
Ladenburg Thalmann acts as placement agent with 8% fee.

item 1.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.